m j alex distribution, LLC

308 south first avenue
mt. vernon, new york 10550

NYS Entity Status
ACTIVE

NYS Filing Date
FEBRUARY 12, 2013

NYS DOS ID#
4359375

County
WESTCHESTER

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2013 - M J ALEX DISTRIBUTION, LLC









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • ‘I’m a Real American Now’: New Citizens Take the Oath, Trump in Mind
    By AVANTIKA CHILKOTI - Wednesday Jul 5, 2017

    One hundred immigrants, including some from countries targeted in the president’s travel ban, celebrated their new citizenship in a ceremony tinged with mixed emotions.

    Source: NYT > Home Page
  • The Info War Is On, And Alex Jones Is Beating Megyn Kelly
    Friday Jun 16, 2017

    An information war is being waged by conspiracy theorist Alex Jones against Megyn Kelly and NBC News, and Jones is winning.

    Source: Media Post: TVBlog
  • How Fake News Turned a Small Town Upside Down
    By CAITLIN DICKERSON - Tuesday Sep 26, 2017

    At the height of the 2016 election, exaggerated reports of a juvenile sex crime brought a media maelstrom to Twin Falls — one the Idaho city still hasn’t recovered from.

    Source: NYT > Home Page
  • WD Navarre Holdings Files for Chapter 11 Protection
    Friday Sep 8, 2017

    WD Navarre Holdings LLC, the corporate parent of technology products distributor WYNIT Distribution LLC, filed for bankruptcy protection Friday.

    Source: The Wall Street Journal: Technology: What's News
  • J&J’s Gorsky on Regulation of ‘Biosimilars’
    Thursday Sep 29, 2016

    Johnson & Johnson Chairman and CEO Alex Gorsky speaks with WSJ’s Laura Landro about the increased regulatory environment and the role of ‘biosimilar’ drugs in the pharma landscape.

    Source: The Wall Street Journal: Viewpoints
  • J&J’s Gorsky on Innovation and Drug Prices
    Thursday Sep 29, 2016

    Alex Gorsky, chairman and CEO of Johnson & Johnson, speaks to WSJ’s Laura Landro about the challenge of balancing perception against profit when it comes to drug prices.

    Source: The Wall Street Journal: Viewpoints